11 Patents
- US124599992025Matrix Metalloprotease-cleavable and Serine Protease-cleavable Substrates and Methods of Use Thereof
CYTOMX THERAPEUTICS, Inc.
0 cites - US123446562025Genetically Engineered T Cells Having Improved Persistence in Culture
CRISPR Therapeutics AG
0 cites - 0 cites
- 0 cites
- US121461572024Anti-ptk7 Immune Cell Cancer Therapy0 cites
- US119266762024Masked Chimeric Antigen Receptor Specific to Tyrosine-protein Kinase Like 7 (PTK7) and Immune Cells Expressing Such
CRISPR THERAPEUTICS AG
0 cites - US117534662023Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, and Methods of Use Thereof
Cytomx Therapeutics, Inc.
0 cites - 0 cites
- US116229772023Materials and Methods for Engineering Cells and Uses Thereof in Immuno-oncology
CRISPR THERAPEUTICS AG
0 cites - US115489432023Matrix Metalloprotease-cleavable and Serine Protease-cleavable Substrates and Methods of Use Thereof
Cytomx Therapeutics, Inc.
0 cites - US115489442023Matrix Metalloprotease-cleavable and Serine Protease-cleavable Substrates and Methods of Use Thereof
Cytomx Therapeutics, Inc.
0 cites